Wanpu Yan

机构：Peking University, Peking University Cancer Hospital, Ministry of Education

发表论文 66 篇 · 总被引 1311 次 · h-index 20

代表论文

• Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial (2023 · Signal Transduction and Targeted Therapy · 被引 83)
• Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial (2022 · Journal of Thoracic Oncology · 被引 34)
• Long-Term Survival and Recurrence Patterns in Locally Advanced Esophageal Squamous Cell Carcinoma Patients with Pathologic Complete Response After Neoadjuvant Chemotherapy Followed by Surgery (2024 · Annals of Surgical Oncology · 被引 26)
• The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer (2024 · Cancer Imaging · 被引 16)
• Adjuvant immunotherapy does not improve survival in non–small cell lung cancer with major/complete pathologic response after induction immunotherapy (2024 · Journal of Thoracic and Cardiovascular Surgery · 被引 14)
• Malignant transformation of heterotopic pancreas as middle esophagus adenocarcinoma—A rare case report and comprehensive literature review (2022 · Thoracic Cancer · 被引 10)